EULAV Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

EULAV Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-195,000	Closed	-$2.62M	–	195
2023 Q1	$2.62M	Hold	195,000	–	–	0.1%	161
2022 Q4	$2.41M	Sell	195,000 -200,000	-51%	-$2.47M	0.1%	157
2022 Q3	$5.51M	Hold	395,000	–	–	0.24%	104
2022 Q2	$5.46M	Sell	395,000 -55,000	-12%	-$760K	0.23%	112
2022 Q1	$7.32M	Hold	450,000	–	–	0.22%	112
2021 Q4	$7.33M	Sell	450,000 -210,000	-32%	-$3.42M	0.19%	132
2021 Q3	$9.8M	Buy	660,000 +325,000	+97%	+$4.83M	0.26%	110
2021 Q2	$6.69M	Hold	335,000	–	–	0.18%	130
2021 Q1	$7.73M	Hold	335,000	–	–	0.21%	120
2020 Q4	$8.28M	Buy	335,000 +184,000	+122%	+$4.55M	0.22%	122
2020 Q3	$6.26M	Hold	151,000	–	–	0.18%	131
2020 Q2	$7.23M	Hold	151,000	–	–	0.24%	112
2020 Q1	$9.51M	Sell	151,000 -16,000	-10%	-$1.01M	0.38%	85
2019 Q4	$20.7M	Sell	167,000 -30,000	-15%	-$3.72M	0.71%	48
2019 Q3	$13.1M	Hold	197,000	–	–	0.48%	72
2019 Q2	$15.7M	Buy	197,000 +17,000	+9%	+$1.35M	0.59%	56
2019 Q1	$20.1M	Buy	180,000 +107,000	+147%	+$11.9M	0.83%	40
2018 Q4	$7.36M	Sell	73,000 -2,000	-3%	-$202K	0.37%	87
2018 Q3	$9.48M	Sell	75,000 -5,000	-6%	-$632K	0.41%	78
2018 Q2	$6.71M	Hold	80,000	–	–	0.31%	106
2018 Q1	$4.92M	Buy	80,000 +14,000	+21%	+$861K	0.24%	134
2017 Q4	$3.86M	Hold	66,000	–	–	0.18%	156
2017 Q3	$3.83M	Buy	66,000 +14,000	+27%	+$813K	0.18%	157
2017 Q2	$6.3M	Hold	52,000	–	–	0.31%	115
2017 Q1	$5.88M	Buy	52,000 +6,000	+13%	+$679K	0.3%	115
2016 Q4	$5M	Hold	46,000	–	–	0.27%	134
2016 Q3	$7.57M	Buy	46,000 +7,000	+18%	+$1.15M	0.4%	93
2016 Q2	$5.57M	Buy	39,000 +8,000	+26%	+$1.14M	0.31%	117
2016 Q1	$3.98M	Buy	31,000 +2,000	+7%	+$257K	0.22%	147
2015 Q4	$4.33M	Buy	29,000 +2,000	+7%	+$299K	0.24%	139
2015 Q3	$4.48M	Buy	27,000 +5,000	+23%	+$829K	0.25%	139
2015 Q2	$5.31M	Buy	22,000 +15,000	+214%	+$3.62M	0.28%	132
2015 Q1	$1.97M	Buy	+7,000	New	+$1.97M	0.1%	240